- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03812757
Supraclavicular Fossa US View for Catheter Positioning in Right Subclavian Central Venous Catheterization
The Supraclavicular Fossa Ultrasound View for Correct Catheter Positioning in Infraclavicular Right Subclavian Central Venous Catheterization
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Central venous catheterization is one of the most common procedures within intensive care medicine. Verification of correct catheter tip placement is a primary aspect of safety and quality of central venous catheterization as malposition may lead to life-threatening complications such as thrombosis, hemothorax, cardiac tamponade, and arrhythmias. Conventional chest x-ray (CXR) is routinely performed after every insertion and is considered gold standard to examine catheter tip location and evaluate for complications such as pneumo- and hemothorax. However, CXR exposes the patient to ionized radiation, requires a considerable amount of time, and is workload-generating for both ICU and radiology staff.
Weber et al has described the use of the right supraclavicular fossa view for real-time ultrasound-guided placement of a central venous catheter (CVC) via the right internal jugular vein (IJV) in adults. This approach has subsequently been validated in a clinical study and has also been used for supraclavicular subclavian line insertion. The approach requires use of a microconvex probe, which couples good image resolution and high scanning depth. The use of a microconvex probe for infraclavicular subclavian central venous catheter (CVC) insertion has been described previously, but this is the first description of the supraclavicular fossa ultrasound view to guide correct catheter tip placement in infraclavicular right subclavian CVC placement.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lund, Sweden, 22185
- Skånes Universitetssjukhus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Indication for central venous catheter placement.
Exclusion Criteria:
- Operator unable to visualize the subclavian vein (e.g., in those with subcutaneous emphysema of the chest wall),
- Subclavian vein catheterization deemed inappropriate by the operator,
- Central line/pacemaker/similar device already in place (risk for misinterpretation of the ultrasound image)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Supraclavicular fossa US scanning
Following insertion of at least 20 cm of the guidewire into the right subclavian vein, the probe is shifted to the right supraclavicular fossa to scan the right internal jugular vein in order to exclude malposition of the guidewire.
The probe is then tilted in a caudal direction to obtain a view of the guidewire within the superior vena cava.
Misplaced guidewires will be corrected under real-time ultrasound guidance.
|
As previously stated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correct catheter tip positioning
Time Frame: Post-procedural x-ray (typically within 24 hours)
|
Optimal placement (cavoatrial junction, distal superior vena cava); acceptable placement (upper part of the right atrium and entire SVC, provided that the axes of the catheter and vein are aligned to reduce the risk of vessel perforation); unacceptable placement (all other locations).
|
Post-procedural x-ray (typically within 24 hours)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mechanical complications within 24 hours
Time Frame: Within 24 hours after central venous catheterization
|
Bleeding, cardiac arrhythmias, arterial puncture/cannulation, pneumothorax.
|
Within 24 hours after central venous catheterization
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ola Borgquist, MD, PhD, Skane University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CVC positioning
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Venous Catheter Placement
-
Universitätsklinikum Hamburg-EppendorfCompletedCentral Venous Catheter PlacementGermany
-
Kutahya Health Sciences UniversityUnknownCentral Venous Catheter PlacementTurkey
-
Zagazig UniversityCompletedCentral Venous Catheter PlacementEgypt
-
University Hospital, AngersUnknownThrombopenia | Central Venous Catheter PlacementFrance
-
Deutsche Interdisziplinäre Vereinigung für Intensiv-...Not yet recruitingCentral Venous CatheterGermany
-
Asklepios Neurological Clinic Bad SalzhausenKerckhoff KlinikCompleted
-
Soroka University Medical CenterUnknownCentral Venous CatheterIsrael
-
University Tunis El ManarCompletedCentral Venous CatheterTunisia
-
B. Braun Melsungen AGRecruitingCentral Venous CatheterGermany, Italy
-
University Tunis El ManarCompleted
Clinical Trials on Supraclavicular fossa US scanning
-
British Columbia Children's HospitalUniversity of British ColumbiaUnknownDevelopmental Dysplasia of the HipCanada
-
International Atomic Energy AgencyInternational Network for Cancer Treatment and ResearchUnknownBreast CancerCuba, Egypt, Ghana, Morocco, Nigeria, Pakistan, Peru, Turkey
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)Completed
-
Zagazig UniversityCompleted
-
CG Oncology, Inc.TerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Bladder Cancer | Carcinoma in Situ Concurrent With Papillary TumorsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast CancerUnited States